Clin Pharmacokinet 51:553572 Rau TF, Lu Q, Sharma S, Sun X, Leary G, Beckman ML, Hou Y, Wainwright MS, Kavanaugh M, Poulsen DJ, Black SM (2012) Oxygen glucose deprivation in rat hippocampal slice cultures results in alterations in carnitine homeostasis and mitochondrial dysfunction
Compared with control, 10, 20, and 40 g/kg BPC-157 suppressed the flinches during the 1st phase but did not suppress the flinches during the 2nd phase
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
In human clinical use, reported side effects are generally mild and transient: Mild injection site redness or discomfort (resolves within hours) Transient nausea in some patients, particularly early in the protocol Mild dizziness or light-headedness (rare, typically dose-related) Temporary fatigue in the first few days (often a sign of active tissue remodeling) No significant systemic toxicity, organ damage, hormonal suppression, or addiction potential has been documented in the published literature
cAMP signaling through Gs-coupled receptors activates protein kinase A (PKA) and exchange protein directly activated by cAMP (EPAC) signals to potentiate insulin or GLP-1 secretion in pancreatic -cells 29 or intestinal L-cells 30,31
